- Home
- CBU vs KYMR Comparison
CBU vs KYMR Comparison
Compare CBU & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBU
- KYMR
- Stock Information
- Founded
- CBU 1866
- KYMR 2015
- Country
- CBU United States
- KYMR United States
- Employees
- CBU N/A
- KYMR N/A
- Industry
- CBU Major Banks
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- CBU Finance
- KYMR Health Care
- Exchange
- CBU Nasdaq
- KYMR Nasdaq
- Market Cap
- CBU 3.0B
- KYMR 3.1B
- IPO Year
- CBU N/A
- KYMR 2020
- Fundamental
- Price
- CBU $56.39
- KYMR $42.63
- Analyst Decision
- CBU Buy
- KYMR Strong Buy
- Analyst Count
- CBU 3
- KYMR 16
- Target Price
- CBU $68.00
- KYMR $58.94
- AVG Volume (30 Days)
- CBU 347.7K
- KYMR 622.1K
- Earning Date
- CBU 07-22-2025
- KYMR 08-11-2025
- Dividend Yield
- CBU 3.33%
- KYMR N/A
- EPS Growth
- CBU 17.62
- KYMR N/A
- EPS
- CBU 3.67
- KYMR N/A
- Revenue
- CBU $756,009,000.00
- KYMR $44,711,000.00
- Revenue This Year
- CBU $13.92
- KYMR $58.26
- Revenue Next Year
- CBU $9.38
- KYMR N/A
- P/E Ratio
- CBU $15.37
- KYMR N/A
- Revenue Growth
- CBU 8.37
- KYMR N/A
- 52 Week Low
- CBU $49.44
- KYMR $19.45
- 52 Week High
- CBU $73.39
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- CBU 52.40
- KYMR 49.94
- Support Level
- CBU $51.12
- KYMR $36.65
- Resistance Level
- CBU $59.31
- KYMR $44.94
- Average True Range (ATR)
- CBU 1.24
- KYMR 1.64
- MACD
- CBU 0.57
- KYMR -0.18
- Stochastic Oscillator
- CBU 64.35
- KYMR 72.14
About CBU Community Bank System Inc.
Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional and governmental customers. The Company also offers comprehensive financial planning, trust administration and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services and Wealth Management Services.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.